Madrigal Pharmaceuticals Inc (MDGL)

77.90 -1.45  -1.83% NASDAQ Oct 21, 12:09 USD

Madrigal Pharmaceuticals Cash from Financing (TTM):

135.61M for June 30, 2021
View 4,000+ financial data types
Browse...
View Full Chart

Cash from Financing (TTM) Chart

Export Data
Save Image
Print Image

Historical Cash from Financing (TTM) Data

View and export this data going back to 2007. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
June 30, 2021 135.61M
March 31, 2021 72.18M
Dec. 31, 2020 5.088M
Sept. 30, 2020 0.459M
June 30, 2020 0.144M
March 31, 2020 0.152M
Dec. 31, 2019 0.235M
Sept. 30, 2019 0.845M
June 30, 2019 1.261M
March 31, 2019 314.15M
Dec. 31, 2018 314.34M
Sept. 30, 2018 449.25M
June 30, 2018 448.80M
March 31, 2018 170.67M
Dec. 31, 2017 173.80M
Sept. 30, 2017 44.23M
June 30, 2017 45.86M
March 31, 2017 17.10M
Dec. 31, 2016 14.45M
Sept. 30, 2016 9.85M
June 30, 2016 -27.01M
March 31, 2016 6.361M
Dec. 31, 2015 3.30M
Sept. 30, 2015 -0.359M
June 30, 2015 60.69M
   
March 31, 2015 75.37M
Dec. 31, 2014 85.30M
Sept. 30, 2014 144.46M
June 30, 2014 118.43M
March 31, 2014 64.38M
Dec. 31, 2013 69.04M
Sept. 30, 2013 70.26M
June 30, 2013 94.42M
March 31, 2013 94.74M
Dec. 31, 2012 115.52M
Sept. 30, 2012 57.37M
June 30, 2012 33.29M
March 31, 2012 67.68M
Dec. 31, 2011 36.74M
Sept. 30, 2011 41.90M
June 30, 2011 55.99M
March 31, 2011 20.91M
Dec. 31, 2010 45.16M
Sept. 30, 2010 39.68M
June 30, 2010 25.22M
March 31, 2010 24.87M
Dec. 31, 2009 -2.129M
Sept. 30, 2009 -2.399M
June 30, 2009 -2.598M
March 31, 2009 -2.30M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

Advertisement

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Benchmarks

Akero Therapeutics Inc 203.13M
908 Devices Inc 136.90M
Twist Bioscience Corp 333.18M

Cash from Financing (TTM) Range, Past 5 Years

Minimum 0.144M Jun 2020
Maximum 449.25M Sep 2018
Average 116.24M

News

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.